Promoter to sell 46.06% stake to two acquirers; open offer triggered
Genomic Valley Biotech's promoter Yogesh Agrawal has signed a Share Purchase Agreement on October 19, 2026 to sell 14.07 lakh equity shares — 46.06% of the voting share capital — to Pankaj Grover and Abhisek Gupta.
By ScoutQuest · · 2 min read
- Shares to be sold
- 14.07 lakh equity shares
- Stake as % of voting share capital
- 46.06%
- Face value per share
- Rs. 10/- each
A change of hands at the top
Genomic Valley Biotech has told the exchanges that its promoter, Yogesh Agrawal, has entered into a Share Purchase Agreement dated October 19, 2026 with two buyers, Pankaj Grover and Abhisek Gupta. Under the agreement the promoter seller proposes to sell his entire shareholding in the company to the acquirers. The update states that consummation of the agreement would result in the acquirers acquiring control over the company.
What changes hands
- The acquirers propose to acquire 14.07 lakh equity shares, representing 46.06% of the voting share capital.
- These are equity shares of face value Rs. 10/- each.
- Before the agreement, the promoter seller held 14.07 lakh shares, or 46.06% of the company.
- Both acquirers, Pankaj Grover and Abhisek Gupta, held Nil shares before the agreement.
The words used matter
The update says the promoter seller "proposes to sell" and that the acquirers "have agreed to purchase" the shares, in the manner and subject to the terms and conditions of the agreement. It also refers to the "proposed transaction" and to what happens "pursuant to the completion of Open Offer and the consummation of the Proposed Transaction". The deal is therefore described in forward-looking terms, with completion and an open offer forming part of the process.
Why an open offer follows
Because the purchase takes the acquirers past the thresholds set in the SEBI (SAST) Regulations, 2011, the transaction attracts an obligation on them to make an open offer to the public shareholders of the company. This is a standard route: when control of a listed company changes hands, smaller public shareholders are given a chance to exit at a price set under those rules.
What happens to the board
On completion of the proposed transaction, the existing promoter directors shall tender their resignation from the board of the company. The acquirers will acquire and exercise control over the company and will be classified as promoters, in line with Regulation 31A of the SEBI (LODR) Regulations, 2015.
Other points recorded
- Except the promoter seller, none of the parties to the agreement is related to the promoter, promoter group or group companies in any manner.
- The transaction is stated not to be a related party transaction.
- No restriction or liability is imposed on the listed company as a result of the agreement.
How to read it
For a retail shareholder, this is a change-of-control announcement: the identity of the promoter, and eventually the board, is set to change, and a mandatory open offer to public shareholders is part of the process. The company's own update sets out the share count, the percentage and the open offer obligation; the commercial terms of the open offer are governed by the SAST process that follows.
Also from Genomic Valley Biotech
Board meeting on 30 October 2026 to consider unaudited standalone results
21 Oct 2026
Open offer for up to 26.00% stake at ₹30 per share after promoter agrees to sell 46.06%
19 Oct 2026
More numbers
- Equity shares proposed to be acquired14,07,000
- Stake as % of voting share capital46.06%
- Promoter seller's holding before the SPA14,07,000
- Promoter seller's holding before the SPA (% of holdings)46.06%
- Face value per equity shareRs. 10/-
- Shares held by each acquirer before the SPANil
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.